Profil
Marco Liguori is currently the General Manager at Orphan Europe SARL.
Previously, he worked as the VP, Director-Special Care & Orphan Drug at Recordati SpA in 2011.
He holds an MBA from INSEAD.
Aktive Positionen von Marco Liguori
| Unternehmen | Position | Beginn |
|---|---|---|
Orphan Europe SARL
 Orphan Europe SARL Pharmaceuticals: MajorHealth Technology Orphan Europe SARL develops and distributes orphan drugs for the treatment of rare diseases. The firm's products include Normosang, Cystagon, Pedea, Carbaglu, Wilzin, Cystadane. The company was founded by William Gunnarsson in 1990 and is headquartered in Puteaux, France. | Präsident | - |
Ehemalige bekannte Positionen von Marco Liguori
| Unternehmen | Position | Ende |
|---|---|---|
| RECORDATI | Corporate Officer/Principal | - |
Ausbildung von Marco Liguori
| INSEAD | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RECORDATI | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Orphan Europe SARL
Orphan Europe SARL Pharmaceuticals: MajorHealth Technology Orphan Europe SARL develops and distributes orphan drugs for the treatment of rare diseases. The firm's products include Normosang, Cystagon, Pedea, Carbaglu, Wilzin, Cystadane. The company was founded by William Gunnarsson in 1990 and is headquartered in Puteaux, France. | Health Technology |
